CAS: 2381089-83-2
A synthetic triple-agonist peptide targeting GIP, GLP-1, and glucagon receptors simultaneously. Retatrutide (CAS 2381089-83-2) is employed in metabolic research studying multi-receptor incretin signaling, energy expenditure, hepatic lipid metabolism, and glucose-dependent insulinotropic mechanisms in preclinical models.
4527.14 g/mol
Store at -20°C, desiccated. Protect from light and moisture.
Reconstitute in sterile bacteriostatic water. Gently swirl; do not vortex. Aliquot and store at 2–8°C.
Research Use Only: This product is intended for in-vitro laboratory research use only. Not for human consumption or therapeutic application. By purchasing, you confirm this product will be used exclusively for qualified research purposes.